Press Release
View printer-friendly version
<< Back
Ian Worden Joins Hythiam as Senior Vice President, Disease Management Operations
Former LifeMasters Executive to Lead Disease Management Operations
LOS ANGELES--(BUSINESS WIRE)--Jan. 30, 2008--Hythiam, Inc. (NASDAQ:HYTM) announced today that healthcare services executive Ian Worden has joined the Company as Senior Vice President, Disease Management Operations. In this capacity, he will oversee the day-to-day operations and expansion of the Company's disease management offering targeted at managed care, self-insured employers, unions and other third party payors.
Prior to joining Hythiam, Worden was Senior Vice President of Strategic Business Operations for LifeMasters Supported SelfCare, Inc., where he was responsible for market positioning, strategic development and maximizing client value of the disease management process by effectively managing contract deliverables. LifeMasters is a leading national provider of health improvement and disease management services. Working with some of the nation's largest health care plans, employers, retirement systems and governmental organizations, including national plans such as Aetna and regional plans such as the Blue Cross Blue Shields, LifeMasters focuses on delivering disease management solutions that improve health outcomes while significantly reducing costs.
"With nearly 14 years of operations experience, Ian has focused on providing and enhancing client value, while developing and managing strategic improvements to business operations," said Terren Peizer, Hythiam's Chairman and CEO. "With the addition of Ian to our team, we will have added the management depth and expertise necessary to effectively oversee and deliver our disease management programs. We look forward to Ian playing a key role as our disease management and managed care initiatives unfold."
About Hythiam, Inc.
Hythiam, Inc. provides behavioral health management services to health plans, employers, criminal justice, and government agencies through a network of licensed and company managed providers. The company approaches the management of behavioral health disorders with a focus on using the latest medical and health technology towards improved outcomes and out-patient treatment. Hythiam also researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment programs. Hythiam offers disease management for substance dependence built around its proprietary PROMETA(R) Treatment Program for alcoholism and dependence to stimulants. The PROMETA(R) Treatment Program, which integrates behavioral, nutritional, and medical components, is available through both licensed treatment providers and company managed PROMETA(R) Centers. Hythiam does not practice medicine or manufacture, distribute, or sell any medications and has no relationship with any manufacturers or distributors of medications used in the PROMETA(R) Treatment Program. For further information, please visit www.hythiam.com.
